Albiglutide
Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin.
Online Inquiry
| CAT# | 10-101-158 |
| CAS | 782500-75-8 |
| Synonyms/Alias | Naliglutide; Albugon;GSK 716155; Naliglutide; Syncria;Eperzan;Tanzeum;UNII-5E7U48495E |
| M.F/Formula | C3232H5032N864O979S41 |
| M.W/Mr. | 72970.4029 |
| Application | Albiglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. |
| Areas of Interest | Type 2 diabetes mellitus |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
